Response to the Complaint Reply

 

Clinical and Governance

Analysis of the Letter Dated 20 April 2026

This section provides a structured, evidence‑based analysis of the formal complaint response issued by the service on 20 April 2026. The purpose is not to dispute opinions, but to examine the reply against established clinical evidence, governance standards, and the documented history of the young person’s neurological visual impairment.

  1. Overview

The response asserts that:

  • the 2026 findings are “accurate and clinically safe”
  • the Special Assessment Clinic is not and has never been a specialist neuro‑visual service
  • continuity of care has not changed
  • the 2026 clinician had full access to historical records
  • no correction or amendment of the 2026 findings is required

These assertions are inconsistent with:

  • the young person’s established neurological baseline
  • the 2018 specialist report
  • the functional‑vision profile
  • the history of specialist oversight
  • the nature of neurological visual impairment
  • the documented contradictions in the 2026 letter

The reply closes the complaint administratively but does not resolve the clinical or governance concerns.

  1. Contradictions Identified in the Response

2.1. Contradiction: Specialist vs Non‑Specialist Service

 

The reply states:

 

“The Special Assessment Clinic is not (and has never been) a specialist neuro‑visual service.”

 

This contradicts:

  • the 30‑year history of specialist neuro‑visual work conducted by the previous clinician
  • the 2018 neuro‑visual report
  • the clinic’s own published academic output
  • the nature of assessments historically provided

This reframing removes responsibility for specialist continuity.

 

2.2. Contradiction: Continuity of Care

 

The reply states:

 

“There has been no change in the care provision.”

 

 

Yet also states:

 

“There is no person who holds responsibility for specialist neuro‑visual care.”

 

These statements cannot both be true.

 

The loss of the only specialist constitutes a change in provision.

 

2.3. Contradiction: Access to Records

 

The reply asserts:

 

“The records were available and have always been accessible.”

 

However, the 2026 letter:

  • does not reference the 2018 findings
  • does not reflect the neurological baseline
  • does not acknowledge the permanent nature of the impairment
  • contradicts the documented presence of vertical nystagmus
  • misinterprets the impairment as intermittent

If the records were accessed, they were not used.

2.4. Contradiction: Nature of the Impairment

 

The reply states:

 

“Nystagmus… was an intermittent, variable condition.”

 

This contradicts the 2018 specialist report, which documents:

 

“Vertical nystagmus present and consistent.”

 

Neurological nystagmus is not intermittent. This is a clinical inaccuracy.

  1. Governance Concerns Raised by the Reply

3.1. Reframing of the Service

 

The reply reframes the clinic as:

  • a teaching clinic
  • a provider of routine NHS sight tests
  • not a specialist service

This reframing:

  • conflicts with the historical role of the clinic
  • removes responsibility for specialist oversight
  • undermines the young person’s established care pathway

3.2. Failure to Address the Core Issue

 

The reply does not address:

  • the contradiction between the 2026 findings and 30 years of evidence
  • the inappropriateness of standard optometric methods
  • the safeguarding implications
  • the functional‑vision risks
  • the loss of specialist continuity

Instead, it asserts accuracy without justification.

 

3.3. Safeguarding Implications

 

The reply does not acknowledge that:

  • inaccurate findings can reduce recognition of risk
  • misinterpretation of neurological impairment can lead to unsafe recommendations
  • vulnerable adults require accurate functional‑vision assessment

This omission is significant.

  1. Conclusion

The response dated 20 April 2026:

  • closes the complaint administratively
  • does not resolve the clinical contradictions
  • does not address the governance concerns
  • does not restore the specialist baseline
  • does not correct the inaccurate 2026 findings
  • does not provide continuity of care
  • does not ensure safeguarding

The governance issues therefore remain open.

This concludes Part 1 — The Beginning.

 

The next section explains why the 2026 assessment was not clinically appropriate, beginning with the neurological nature of the young person’s impairment and the specialist baseline that guided their care for more than three decades.

 

 

Next

Part 2: Why the 2026 Assessment Was Not Clinically Appropriate

 

 

 

 

Design & Copyright Owner Maureen Booth-Martin (MBM) © All rights reserved

UA-54289644-1